DIALYSIS · CCN 212650

DaVita Aberdeen Dialysis

ABERDEEN, MD 21001

DialysisProfitDaVita
$5.5M
TOTAL REVENUE
41.0%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.5M
Total costs
$3.3M
Operating income (rev − costs)
$2.3M
Operating margin
41.0%
Total charges
$5.6M
Total treatments
12,018
Dialysis stations
15

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.3887—
Fistula Rate
DFC_FISTULA_RATE
6797—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.2146—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
113.988—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.16——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1297—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
25.1359—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
12.368—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
25.749—
Standardized ED Visits Ratio
DFC_SEDR
0.563—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
32.151—